| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |